-- Scott Roberts
FRIDAY, Jan. 25 (HealthDay News) -- The drug Oxytrol has been
approved by the U.S. Food and Drug Administration as the first
over-the-counter treatment for women 18 and older with overactive
Overactive bladder is characterized by symptoms including
leakage, frequent urination and feeling the sudden and urgent need
to urinate. The condition affects some 33 million Americans, mostly
Oxytrol contains oxybutynin, among a class of drugs called
anticholinergics that are designed to relax the bladder muscle.
Oxytrol is a patch applied to the skin every four days, the FDA
said in a news release.
The drug will remain available for adult men by prescription
only, the agency said.
Side effects reported during clinical testing included skin
irritation at the patch site, dry mouth and constipation.
Oxytrol for Women is marketed by Merck, based in Whitehouse
To learn more about
overactive bladder, visit the U.S. Department of Health and Human Services.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.